NEW YORK (Reuters Health) – High-dose chemo followed by autologous stem-cell transplantation achieves good results in patients with relapsed Hodgkin’s lymphoma, and outcomes are not improved by additional…
Pedram Mizani, MD, MHSA, CEO of AmeriClerkships, speaks at the 2010 AMA Annual Meeting, discusses the concept of acculturation. This means training doctors from early on learn culturally…
Emru U. Seli, MD, Assistant Professor and Director of the Third Party Reproductive Program at Yale University, discusses fertility preservation for women who are about to undergo treatment…
Emru U. Seli, MD, Assistant Professor and Director of the Third Party Reproductive Program at Yale University, discusses fertility preservation for women who are about to undergo treatment…
Michael J. Manos, MD, PhD, Head of the Center for Pediatric Behavioral Health, Children’s Hospital, Cleveland Clinic, discusses ADHD and describes some of the benefits of having this…
NEW YORK (Reuters Health) – Results of a clinical trial of the new, long-acting neuraminidase inhibitor laninamivir octanoate show that it is not inferior to oseltamivir in treating…
NEW YORK (Reuters Health) – Senior investigator Dr. Henry T. Akinbi of Cincinnati Children’s Hospital Medical Center and University of Cincinnati College of Medicine, provided this perspective in…
NEW YORK (Reuters Health) – In patients with mixed dyslipidemia, fenofibric acid added to atorvastatin and ezetimibe results in improved lipid and non-lipid levels, according to a report…
NEW YORK (Reuters Health) – When sepsis is suspected in a newborn infant, a complete blood count as a test for infection improves “dramatically” with increasing time over…
NEW YORK (Reuters Health) – For patients with rheumatoid arthritis (RA), treatment with anti-tumor necrosis factor (TNF) agents appears to reduce their risk of cardiovascular events, including MI…
